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Analogous to transmission of human T-cell leukemia virus type 1 (HTLV-1) in vivo, an in vitro cell-to-cell infection model was
established by coculturing MT-2 cells as virus donors and HUT78 cells as recipients. At a donor:recipient ratio of 1:2, cell
fusion occurred and a new round of HTLV-1 genome replication was initiated in the cocultured cells. Newly synthesized
unintegrated viral DNA was detected by Southern blot within 4–8 h and then increased between 8 and 48 h following cell
mixing. The most dominant species of unintegrated viral DNA was 3.7 kb in size which hybridized to a full-length HTLV-1 DNA
probe but not to a KpnI viral DNA fragment that is absent from a defective proviral genome that has been previously identified
in MT-2 cells. Northern blot analysis showed large amounts of viral RNA in the virus donor cells and in the cocultured cells,
with a 3.4-kb species being the most abundant. This 3.4-kb RNA gave a pattern identical to that of the 3.7-kb unintegrated
viral DNA in hybridization studies using the two probes. It seems likely that the unspliced RNA transcript from the defective
proviral genome in MT-2 cells was effectively reverse transcribed upon initiation of cell-to-cell viral transmission to
susceptible HUT78 cells. Despite active de novo reverse transcription, however, viral RNA levels remained unchanged
following cell-to-cell transmission of HTLV-1 infection and no viral antigen production could be attributed to the newly
initiated round of viral genome replication. As an abortive infection model this simple cell-to-cell infection system warrants
more detailed study as it has the potential to provide reliable information regarding the early events in HTLV-1 transmission
and infection. © 1998 Academic Press
INTRODUCTION
Human T-cell leukemia virus type I (HTLV-I) is the
etiological agent for adult T-cell leukemia-lymphoma
(ATLL) and is closely associated with the neurological
disease tropical spastic paraparesis (TSP) or HTLV-I-
associated myelopathy (HAM) (Poiesz et al., 1980; Hi-
numa et al., 1981; Gessain et al., 1985, 1986). The virus is
endemic in Japan and other parts of Asia, the Carribean
Basin, and West and Central Africa (Gessain, 1996). The
number of people around the world infected with HTLV-I
has been estimated as between 10 and 20 million (De
The and Bomford, 1993). High prevalence of HTLV-I an-
tibodies has also been found in Melanesia and among
Australian Aboriginals (Asher et al., 1988; May et al.,
1988; Bastian et al., 1993).
HTLV-I is a member of the HTLV-BLV genus of the
Retroviridae. It causes leukemia/lymphoma in ,5% of
infected individuals and transforms T-cells in vitro. How-
ever, the tumorigenic mechanism(s) of this virus is
unique. HTLV-I does not harbor a viral oncogene and it is
not known to frequently activate cellular oncogenes by
insertional mutagenesis. Furthermore, in contrast to
other members of the oncovirus subfamily (most of which
are simple retroviruses) HTLV-I is a complex retrovirus
with regulatory genes in addition to the gag, pol, and env
genes common to all retroviruses. In this respect, HTLV-I
is akin to HIV and other lentiviruses (Cullen, 1991). In
addition to T-cell transformation, studies on HTLV-I have
focussed on its epidemiology, its geographical distribu-
tion, and its etiological roles in ATLL and HAM/TSP and
have then moved to molecular characterization of its
genome structure and the molecular biology of the tax
and rex transactivating proteins (Cann and Chen, 1996;
Uchiyama, 1997). There are significant gaps in our
knowledge regarding the virus–cell interaction and rep-
lication of HTLV-I, and most of our assumptions about the
strategy and mechanism of HTLV-I replication are based
on extrapolation from other retroviruses. The cellular
receptor(s) for HTLV-I, known to be determined by human
chromosome 17, has yet to be fully identified (Sommerfelt
et al., 1988; Gavalchin et al., 1993). Although there are
reports that HTLV-I-free virions can infect human periph-
eral blood mononuclear cells, monocytes–macrophages
and microglial cells, and some nonlymphoid cell lines in
vitro (Clapham et al., 1983; Hoffman et al., 1992; Fan et al.,
1992; Koralnik et al., 1992), cell-free virus is generally
poorly infectious to the major cell type that is susceptible
in vivo—human CD41 T-cells (Richardson et al., 1990;
Yamada et al., 1993; Cann and Chen, 1996)—and the
reasons for that are not clear. The typical lack of infec-
tivity of free virions makes it difficult to quantitate virus
infection. The fundamental requirement in studying the
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biochemistry of virus replication, a one-step virus infec-
tion model, has been difficult to achieve for HTLV-I.
Unlike other oncoviruses or lentiviruses, HTLV-I has not
been demonstrated to cause lytic infection in vitro. The
spread of HTLV-I in vivo is predominantly mediated by
cell-associated virus and cell-to-cell transmission of in-
fection (Cann and Chen, 1996; Uchiyama, 1997).
In this report, we describe a model system for inves-
tigating the early events of HTLV-I replication in vitro.
Cell-to-cell viral transmission is achieved by coculturing
MT-2 cells (a cell line productively infected with HTLV-I)
as virus donor cells and HUT78 cells (a human CD41
lymphoid cell line) as recipient cells. At a donor:recipient
ratio of 1:2, the mixed culture showed the initiation of a
new round of HTLV-I replication. De novo reverse tran-
scription was demonstrated by Southern blot detection
of newly synthesized extrachromosomal HTLV-I DNA
within 4–8 h after cell-to-cell transmission of the virus
and the amounts of unintegrated viral DNA increased
between 8 and 48 h following infection. Although the
cell-to-cell infection did not lead to a fully productive
infection, this model system mimics the natural mecha-
nism of HTLV-I transmission and infection in vivo and
provides a simple, yet powerful, tool to study the early
events in HTLV-I replication cycle.
RESULTS
Following coculturing MT-2 cells and HUT78 cells at a
ratio of 1:2, cell fusion was first seen at ;8 h post-cell
mixing. Syncytia or multinucleated giant cells become
visible at 12 h post-cell mixing. By 24 and 48 h after cell
mixing, a significant proportion (20–30%) of the mixed
cell population was found to be associated with multinu-
cleated giant cells. Figure 2 shows typical syncytium
formation 24 h after cocultivation of MT-2 cells with
HUT78 cells. A new round of HTLV-I genome replication,
distinct and distinguishable from virus production in the
MT-2 viral donor cells, occurred in this coculture-based
cell-to-cell HTLV-I infection system with de novo reverse
transcription of HTLV-I RNAs into free, unintegrated viral
DNA species.
The levels of unintegrated HTLV-I DNA following cell-
to-cell transmission of viral infection was monitored by
Southern blot (Fig. 3A). In uninfected HUT78 cells, viral
donor MT-2 cells and cocultured cells at the time of cell
mixing (0 h), levels of extrachromosomal viral DNA in the
Hirt supernatant were below the detection limit of this
method. By 4 h, newly synthesized viral DNA appeared
and from 8 h post-cell mixing to 48 h post-cell mixing,
large quantities of HTLV-I DNA were detected. The sharp
FIG. 1. Viral nucleic acids in MT-2 cells. (A) Competent HTLV-I proviral genome and positions of the NdeI and KpnI DNA fragments which are used
as probes. (B) Major defective HTLV-I proviral genome. Dotted lines between A and B depict the deletion. (C) Major RNA transcripts from A. (D) Major
RNA transcripts from B.
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increase of newly made viral DNA clearly indicated a de
novo reverse transcription process as previously seen
with cell-to-cell HIV infection (Li et al., 1992). In order to
further confirm that the DNA species are wholly pro-
duced by de novo reverse transcription, both the MT-2
cells and the HUT78 cells were treated with 20 mM
azidothymidine (AZT) for 18 h, mixed, and then cocultured
in the continued presence of the drug (Li et al., 1992;
Macchi et al., 1997). Episomal viral DNA levels were
monitored by Southern blotting. As expected, AZT treat-
ment completely abolished HTLV-I DNA production (data
not shown).
Several bands of HTLV-I DNA were detected. The top
band, ;9 kb in size, is thought to correspond to the
FIG. 2. Syncytium formation in cocultured cells. (A) HUT78 cells (original magnification, 1003). (B) MT2 cells (original magnification, 1003). (C)
Syncytia formed 24 h after coculture of HUT78 cells and MT2 cells at a ratio of 2:1 (original magnification, 2003).
FIG. 3. Viral DNA synthesis following cell-to-cell transmission of HTLV-I. Extrachromosomal DNA preparations from 1 3 106 HUT78 cells (lane 1),
MT2 cells (lane 2), or cocultured cells (HUT78:MT2 5 2:1) at the time of cell mixing (lane 3) or 4, 8, 12, 16, 24, and 48 h after cell mixing (lanes 4–9)
were separated by agarose gel electrophoresis followed by Southern blotting. One of two identical filters (A) was hybridized with 32P-labeled NdeI
fragment viral DNA probe and the other (B), 32P-labeled KpnI fragment viral DNA probe as described under Materials and Methods and the legend
to Fig. 1. Lane M, 32P-labeled l-HindIII fragments used as size markers.
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full-length linear unintegrated HTLV-I DNA. The identities
of the other upper bands are unclear, but may represent
reverse transcripts of minor defective viral RNA (see
below). The most prominent viral DNA band (arrow) is
;3.7 kb in size and is not a circular form of full-length
viral DNA as digestion with XbaI, which cuts HTLV-I DNA
only once at position 4104 (Seiki et al., 1983), did not
convert it to a full-length linear DNA (data not shown).
MT-2 cells are known to harbor defective, subgenomic
proviral sequences (‘‘defective proviral genomes’’) which
are able to produce viral RNA transcripts. The major
reported defective proviral genome in MT-2 cells was 3.7
kb in length with a large deletion spanning part of the
gag gene, the entire pro/pol gene, and almost the entire
env gene. The characterized viral RNA species tran-
scribed from this defective proviral genome include P28
RNA and P21X RNA named after their protein products
(Orita et al., 1993; see Fig. 1). The P28 RNA is the
‘‘full-length transcript’’ of the defective proviral genome. It
contains the primer binding site (PBS) and the viral RNA
packaging sequences. Thus P28 RNA in the presence of
reverse transcriptase and other viral proteins (present in
MT-2 cells) would be potentially capable of being pack-
aged and reverse transcribed upon entering susceptible
cells. We therefore used a KpnI fragment of HTLV-I pro-
viral DNA, which is located in the middle of the deleted
sequence absent from the defective proviral genome
(Fig. 1), to probe an identical Southern filter. Figure 3B
shows that the predominant 3.7-kb band of the newly
made viral DNA did not specifically hybridize to this
differential probe while the upper bands still did. These
results strongly suggested that the unintegrated 3.7-kb
viral DNA was likely to be the reverse transcript of the
P28 RNA expressed from the defective proviral genome
in MT-2 cells. Furthermore, the dominant intensity of the
3.7-kb DNA in the Southern blot (Fig. 3A) suggests that
the P28 RNA should be the most dominant viral RNA
species in MT-2 cells and in the cocultured cells.
To examine the sizes and levels of RNA species used
as templates for the newly reverse-transcribed DNA, two
identical Northern blot filters, containing RNA samples
isolated from cells collected at different time points fol-
lowing cell-to-cell HTLV-I infection, were hybridized with
either the near full-length 8.2-kb NdeI fragment probe
(Fig. 4A) or the differential 2.9-kb KpnI fragment probe
(Fig. 4B). The results demonstrate that the mixed cells at
the beginning of the experiment (0 h) did contain large
quantities of viral RNA. The most prominent RNA species
detected by the NdeI probe was the 3.4-kb P28 RNA
(arrow), while the cells also contained full-length HTLV-1
RNA, spliced mRNAs from the full-length transcript, and
other minor transcripts possibly from defective proviral
sequences. The KpnI probe, while hybridizing to nearly
all other viral RNA bands, did not specifically hybridize to
this most prominent 3.4-kb viral RNA (Fig. 4B), thereby
confirming that this was derived from the major ‘‘defective
proviral genome’’ previously identified in MT-2 cells (Orita
et al., 1993). Cells at different time points after cell-to-cell
viral infection continued to contain large amounts of viral
RNAs with the 3.4-kb RNA as the dominant species, but
we could not demonstrate an increase of this RNA or the
viral gag/pro/pol RNA or other RNA species during the
48 h following cell-to-cell HTLV-I infection (Fig. 4). This
suggests that the newly made viral DNA species in this
model system were unable to function as efficient tran-
scription templates. Thus this cell-to-cell HTLV-1 infec-
tion model may be abortive and supports only the early
events in HTLV-1 replication.
To confirm that the limited extent viral replication could
proceed in this cell-to-cell HTLV-1 infection model, the
release of HTLV-1 P19 viral core antigen into the culture
supernatants of cocultured cells in the absence or pres-
ence of AZT was determined using a commercial assay
(Retro-Tek HTLV-1 P19 ELISA, Cellular Products Inc.,
U.S.A.). Figure 5 shows that while there was a gradual
increase of supernatant P19 antigen over the 48-h cell-
to-cell infection period, this could not be attributed to the
new round of HTLV-1 replication. AZT-treated cultures,
where de novo reverse transcription was effectively abol-
ished, showed a similar pattern of P19 antigen increase.
Moreover, MT-2 cells alone demonstrated similar in-
crease in supernatant P19 antigen over the same period.
After 48 h, the control MT-2 cells had doubled in cell
number and the increase in P19 antigen levels over the
48-h period was probably a combined result of increased
cell number and accumulation of viral antigen in the
supernatants, presumably associated with viral particles.
Taken together, our data suggest that the coculturing of
FIG. 4. Viral RNA levels following cell-to-cell transmission of HTLV-1.
Cytoplasmic RNA preparations from 1 3 106 cocultured cells (HUT78:
MT2 5 2:1) at the time of cell mixing or 8, 12, 24, and 48 h after cell
mixing (lanes 1–5) were separated by denaturing agarose gel electro-
phoresis followed by Northern blotting. One of two identical filters (A)
was hybridized with 32P-labeled NdeI fragment viral DNA probe and the
other (B) with 32P-labeled KpnI fragment viral DNA probe. Lane M,
32P-labeled RNA size marker (RiboMark, Promega).
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MT-2 cells and HUT78 cells results in a new round of
HTLV-1 replication initiated by fusion and cell-to-cell
transmission of the virus. This is evidenced by the dra-
matic onset of de novo viral reverse transcription. How-
ever, this new round of HTLV-1 replication is aborted at
one or more of the stages between viral DNA synthesis
and viral RNA expression and does not lead to progeny
virus production.
DISCUSSION
The primary objective of the current study was to
establish a cell culture system that would allow detailed
studies of the early events in the HTLV-I replication cycle.
Coculturing of lethally treated viral donor cells with un-
infected susceptible cells has been used as an assay
system to study HTLV-I transformation of T cells
(Yamamoto et al., 1982; Merl et al., 1984). It has been
widely assumed that coculturing systems were not suit-
able for studying HTLV-I replication kinetics because the
donor cells already contained viral nucleic acids and
viral proteins (Fan et al., 1992). However, studies on
cell-to-cell infection with other retroviruses indicate this
may not necessarily be the case. Most cell lines persis-
tently infected with retroviruses have been selected ap-
parently after integration that leads to limited virus pro-
duction tolerated by the host cells. Furthermore, possible
reinfection of the producer cells with progeny virus and
possible reverse transcription of the outgoing viral RNA
transcribed from the provirus of the producer cells must
have been curbed to low levels to allow the persistent
viral producer cells to be selected in the first place.
Working with cell-to-cell transmission of HIV infection,
we and others have shown that the kinetics of HIV
replication in general, and de novo reverse transcription
in particular, could be studied in great detail using co-
culture of persistently infected virus donor cells and fully
susceptible recipient cells (Li and Burrell, 1992; Li et al.,
1992, 1993, 1994; Sato et al., 1992; Barbosa et al., 1994;
Karageorgos et al., 1995; Davis et al., 1997). The cocul-
ture model system described in this report demonstrated
that it is feasible to study de novo HTLV-I reverse tran-
scription using MT-2 cells as viral donor cells and HUT78
cells as recipient cells. Large amounts of viral DNA were
synthesized in a very short time frame. Conventional
Southern blot hybridization was quite adequate to follow
viral DNA synthesis. This has made the model system
powerful and reliable. MT-2 cells were chosen because
these cells are the most widely used HTLV-I producer
cells. In addition, compared with other HTLV-I donor
cells, MT-2 cells have been shown to consistently trans-
form T cells—an event mediated by successful trans-
mission of virus from the donor to the recipient cells
(Miyoshi et al., 1981; Yamamoto et al., 1982; Merl et al.,
1984).
The presence of a 3.7-kb defective HTLV-I provirus
genome and possibly other defective HTLV-I sequences
in MT-2 cells (Orita et al., 1993) has resulted in a com-
plicated pattern of viral DNA synthesis following cell-to-
cell viral infection presumably mediated by cell fusion.
Using a near full-length viral DNA probe that would
detect all viral specific sequences, it was shown that the
most predominant newly made unintegrated viral DNA
was a 3.7-kb species. A differential viral DNA probe that
represents the region absent from the predominant de-
fective proviral genome in MT-2 cells failed to hybridize
to the most prominent free viral DNA. Corresponding
Northern blot analysis demonstrated a predominant
3.4-kb RNA species which also failed to hybridize to the
FIG. 5. HTLV-1 P19 antigen levels in supernatants of cocultured cells. 8.3 3 105 MT-2 cells, either alone or mixed with 1.66 3 106 HUT78 cells, were
cultured in 5 ml RMPI 1640 medium supplemented with 10% FCS. At the time of cell mixing (0 h) and 4, 8, 16, 24, 36, and 48 h after coculturing, an
aliquot of culture supernatants was harvested and the HTLV-1 P19 antigen level measured as described under Materials and Methods. , MT-2 cell
alone; E, mixed cells. An identical set of MT-2 cells and mixed cells were pretreated with 20 mM AZT and then cultured in the presence of 20 mM
AZT during the experiment. n, MT-2 cells with AZT; {, mixed cells with AZT.
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differential probe. These results strongly suggest that in
addition to the full-length viral RNA the defective 3.4-kb
RNA, presumably identical to the P28 RNA described by
Orita et al., (1993), is actively reverse transcribed. The
3.4-kb RNA lacks sequences coding viral enzymes and
envelope proteins and therefore the reverse transcrip-
tase made from the full-length, competent viral genome
is required for it to be reverse transcribed. Orita et al.
estimated that there were 1–3 copies of complete inte-
grated proviral genome and 20–40 copies of the 3.7-kb
integrated defective proviral genome in MT-2 cells. Al-
though we have not quantified the copy numbers of the
unintegrated full-length and the 3.7-kb viral DNA species
in our experimental system, the relative intensities of the
corresponding bands appeared similar to those de-
scribed for integrated DNA in the earlier study.
It is generally believed from earlier studies with type C
oncoviruses that retroviral viral reverse transcriptase
(and other enzymes) is cleaved from a gag-pol precursor
and matures during or after virion budding (Witte and
Baltimore, 1978; Eisenman et al., 1980). If this applies to
HTLV-I, then it would be interesting to investigate
whether viral envelope proteins and the gag- and gag-
pro-pol precursor proteins derived from the complete
viral transcript would interact with the potentially ‘‘pack-
agable’’ 3.4-kb RNA and, presumably, to form defective
virions containing 3.4-kb defective RNA genome. Alter-
natively, mature HTLV-I reverse transcriptase may be
present in MT-2 cells, which would start reverse tran-
scribing both the full-length and the 3.4-kb defective
HTLV-I RNA upon cell fusion in a manner similar to the
commencement of reverse transcription upon initiation
of cell-to-cell transmission of HIV infection (Li et al.,
1994).
Our Northern blot analysis failed to detect any in-
crease in viral RNA levels following cell-to-cell HTLV-I
infection. Semiquantitative RT-PCR analysis of the full-
length (gag-pro-pol) HTLV-I RNA following cell-to-cell in-
fection also could not detect significant increase in the
mRNA (Duthy, McInnes, and Li, unpublished). Consistent
with this, there was no evidence for progeny virus pro-
duction that could be attributed to the new round of virus
genome replication. It is possible that the extraordinarily
large amount of the 3.4-kb RNA accumulated in MT-2
viral donor cells (Fig. 4) may have facilitated the dramatic
de novo reverse transcription. Whether the newly syn-
thesized subgenomic viral DNA can then integrate and
what effects its presence may have on the synthesis,
integration, and expression of the full-length viral DNA
are at present unknown. The abortive nature of this
cell-to-cell HTLV-1 infection model is in contrast to sim-
ilar cell-to-cell HIV infection models where de novo viral
reverse transcription is followed by new viral RNA ex-
pression and progeny viral production (Li and Burrell,
1992; Li et al., 1992; Sato et al., 1992; Barbosa et al., 1994;
Davis et al., 1997). The major advantage of this abortive
viral infection model is that it allows a ‘‘clean’’ dissection
of the early events of HTLV-1 replication, including the
mechanisms of cell-to-cell transmission and activation of
reverse transcription, which remain poorly understood
(Li et al., 1994).
MATERIALS AND METHODS
Cells and virus infection
HUT78 cells were from the AIDS research and Refer-
ence Reagent Program, NIAID, NIH. MT-2 cells (Miyoshi
et al., 1981) were from Dr. Dale McPhee’s Laboratory,
Macfarlane Burnet Centre for Medical Research, Mel-
bourne, Australia. All cells were cultured in RPMI 1640
growth medium supplemented with 10% fetal calf serum
at a cell density of ;0.5 3 106 cells/ml.
To ensure that cells were under similar growth condi-
tions throughout this study, each of the cell types was
routinely subcultured 18–20 h before use at a cell density
of 1 3 106 cells/ml. Cells were spun down, washed once
with serum-free RPMI 1640 at 37°C, resuspended in full
growth medium, and mixed and cocultured at a ratio of
one MT-2 virus donor cell to two recipient HUT78 cells.
Immediately after cell mix (0 h), and 4, 8, 12, 16, 24, and
48 h after coculture, cell culture supernatants were har-
vested for detection of viral antigen P19 production using
a commercial kit (Retro-Tek HTLV P19 antigen ELISA,
Cellular Products Inc.) according to manufacturer’s in-
structions. Cells were also harvested at the same time
points by low-speed centrifugation, washed once with
phosphate-buffered saline, and used for analysis of ex-
trachromosomal viral DNA or viral RNA. When AZT was
used, MT-2 cells and HUT78 cells were preincubated in
growth medium containing 20 mM AZT for 18 h before
cell mixing, and 20 mM AZT was maintained in the
cocultured cells for the entire duration of the experiment
(Li et al., 1992).
Viral nucleic acids analysis
Extrachromosomal DNA from control or infected cells
was separated from chromosomal DNA by the Hirt
method in the presence of 500 mg/ml proteinase K as
described previously (Hirt, 1967; Li and Burrell, 1992).
The Hirt supernatants were extracted twice with phenol:
chloroform:isoamylalcohol (25:24:1) and the DNA was
precipitated by ethanol, treated with 100 mg/ml RNase A
for 1 h at 37°C, extracted with phenol:chloroform:isoamy-
lalcohol once more, and reprecipitated. Extrachromo-
somal DNA extracted from 1 3 106 mixed cells was
analyzed by electrophoresis on 0.8% agarose gels fol-
lowed by Southern blotting according to standard tech-
niques (Sambrook et al., 1989). Viral DNA was detected
by hybridization with 32P-labeled Gigaprimer (Bresatec,
Adelaide, Australia) probes. The NdeI fragment (;8.2 kb)
of plasmid pACH (Kimata et al., 1994) was used as
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near-full-length HTLV-I probe and a KpnI fragment (;2.9
kb, generated from the NdeI fragment) was used as a
differential probe (see Fig. 1).
Cytoplasmic RNA was isolated by the method of
Gough, treated with RNase-free DNase (Boehringer) at
0.5 U/ml, 37°C for 10 min, and viral RNA was analyzed by
gel electrophoresis and Northern blotting followed by
hybridization with 32P-labeled Gigaprimer probes men-
tioned above (Gough, 1988; Kok et al., 1993).
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